Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $44.6000 (-1.98%) ($44.6000 - $45.7000) on Wed. Oct. 14, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.11% (three month average) | RSI | 48 | Latest Price | $44.6000(-1.98%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.7% a day on average for past five trading days. | Weekly Trend | CAPR advances 4.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) SKYY(8%) PEJ(7%) VT(7%) XLF(7%) EWG(6%) | Factors Impacting CAPR price | CAPR will decline at least -2.055% in a week (0% probabilities). VIXM(-5%) TLT(-5%) SHY(-3%) GLD(-3%) BND(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.055% (StdDev 4.11%) | Hourly BBV | 0 () | Intraday Trend | -2.4% | | | |
|
5 Day Moving Average | $44.68(-0.18%) | 10 Day Moving Average | $43.87(1.66%) | 20 Day Moving Average | $43.34(2.91%) | To recent high | -12.5% | To recent low | 15.5% | Market Cap | $879m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |